Estados Unidos · Bolsas y cotizaciones · Nasdaq

PTC Therapeutics Board Approves $500 Mln Share Buyback

Publicado por Nasdaq · Estados Unidos hace 1 h

(RTTNews) - PTC Therapeutics, Inc. (PTCT), a biopharmaceutical company, said Tuesday that its Board of Directors has authorized a share repurchase program of up to $500 million.

Leer el artículo completo en Nasdaq Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.nasdaq.com)

PTC Therapeutics Board Approves $500 Mln Share Buyback

También te puede interesar

Indian Refiner BPCL Buys U.S. WTI Crude Oil Cargo

Bitcoin ETF Tracker

What to know about the possibility of federal officers showing up at polling stations

Here’s How Much Traders Expect Palantir Stock to Move After Earnings

Nasdaq and S&P 500 Index Lose Momentum, Pull Down Market

Introducing new self-learning context enrichment in Knowledge Catalog

PTC Therapeutics Board Approves $500 Mln Share Buyback

Compartir

También te puede interesar

Indian Refiner BPCL Buys U.S. WTI Crude Oil Cargo

Bitcoin ETF Tracker

What to know about the possibility of federal officers showing up at polling stations

Here’s How Much Traders Expect Palantir Stock to Move After Earnings

Nasdaq and S&P 500 Index Lose Momentum, Pull Down Market

Introducing new self-learning context enrichment in Knowledge Catalog